Skip to main content
European Heart Journal. Cardiovascular Pharmacotherapy logoLink to European Heart Journal. Cardiovascular Pharmacotherapy
. 2026 May 18;12(4):345. doi: 10.1093/ehjcvp/pvag035

Correction to: Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus

PMCID: PMC13367242  PMID: 42149576

This is a correction to: Heinz Drexel, Andreas Festa, Thomas A Schmidt, Bianca Rocca, Dobromir Dobrev, Stefan Agewall, Juan Tamargo, Susanne Kaser, Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus, European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 8, December 2025, Pages 698–711, https://doi.org/10.1093/ehjcvp/pvaf076

In the originally published manuscript, the ‘Conflict of interest’ section was incomplete. It has now been corrected to read: “H.D., S.A., and J.T. are Editors of the European Heart Journal—Cardiovascular Pharmacotherapy and were not involved in the peer review process or publication decision. A.F., T.A.S., B.R., D.D., and S.K. declared no conflict of interest”.


Articles from European Heart Journal. Cardiovascular Pharmacotherapy are provided here courtesy of Oxford University Press

RESOURCES